Hippocampal sclerosis is a frequent pathological finding in patients with temporal lobe epilepsy and can be caused by prolonged single or repeated brief seizures. Both DNA damage and endoplasmic reticulum stress have been implicated as underlying molecular mechanisms in seizure-induced brain injury. The CCAAT/enhancer-binding protein homologous protein (CHOP) is a transcriptional regulator induced downstream of DNA damage and endoplasmic reticulum stress, which can promote or inhibit apoptosis according to context. Recent work has proposed inhibition of CHOP as a suitable neuroprotective strategy. Here, we show that transcript and protein levels of CHOP increase in surviving subfields of the hippocampus after prolonged seizures (status epilepticus) in mouse models. CHOP was also elevated in the hippocampus from epileptic mice and patients with pharmacoresistant epilepsy. The hippocampus of CHOP-deficient mice was much more vulnerable to damage in mouse models of status epilepticus. Moreover, compared with wild-type animals, CHOP-deficient mice subject to status epilepticus developed more spontaneous seizures, displayed protracted hippocampal neurodegeneration and a deficit in a hippocampus-dependent object-place recognition task. The absence of CHOP was associated with a supra-maximal induction of p53 after status epilepticus, and inhibition of p53 abolished the cell death-promoting consequences of CHOP deficiency. The protective effect of CHOP could be partly explained by activating transcription of murine double minute 2 that targets p53 for degradation. These data demonstrate that CHOP is required for neuronal survival after seizures and caution against inhibition of CHOP as a neuroprotective strategy where excitotoxicity is an underlying pathomechanism.
Introduction
Epilepsy is a common, chronic neurological disorder characterized by recurrent, unprovoked seizures that are the result of abnormally synchronized neuronal discharges in the brain (Chang and Lowenstein, 2003) . The aetiology of temporal lobe epilepsy, the most common and refractory syndrome in adults, is often unknown, but hippocampal sclerosis, comprising selective neuron loss with attendant gliosis, is present in about two-thirds of patients. Hippocampal sclerosis may be both cause and consequence of seizures, and recurring seizures contribute to progressive damage and cognitive impairments (Falconer, 1974; Kotloski et al., 2002; Mathern et al., 2002; Bernasconi and Bernhardt, 2010) .
Preventing hippocampal damage is a potential therapeutic strategy for mitigation or prevention of epilepsy (Falconer, 1974; Fujikawa, 2006; Acharya et al., 2008; Sloviter, 2011) . The pathomechanisms underlying seizure-induced neuronal death, however, are not fully understood. Prolonged glutamate receptor activation during a seizure leads to the loss of intracellular calcium homeostasis, oxidative stress, DNA damage and intracellular organelle dysfunction (Fujikawa, 2006) . A biochemical signature consistent with neuronal apoptosis is also present, and targeting these pathways offers novel approaches for preventing hippocampal damage and post-injury spontaneous seizures (Henshall and Murphy, 2008; Engel et al., 2011) .
The endoplasmic reticulum performs several functions, including protein folding and trafficking and regulating intracellular calcium levels (Xu et al., 2005) . Seizure activity results in the activation of an endoplasmic reticulum stress response (Pelletier et al., 1999; Kitao et al., 2001; Yamamoto et al., 2006; Sokka et al., 2007) . Endoplasmic reticulum stress is normally sensed by three upstream signalling proteins; the kinases PERK [protein kinase RNA (PKR)-like ER (endoplasmic reticulum) kinase] and IRE1 (inositol-requiring protein 1) and the transcription factor ATF6 (activating transcription factor 6). Together, these initiate the unfolded protein response that functions to upregulate endoplasmic reticulum chaperones, such as glucose-regulated protein 78, inhibit most protein translation and activate proteases involved in the degradation of misfolded proteins (Xu et al., 2005; Hetz, 2012) . Prolonged endoplasmic reticulum stress, as well as DNA damage, can induce apoptosis through CCAAT/ enhancer-binding protein homologous protein (CHOP) (Zinszner et al., 1998; Oyadomari and Mori, 2004; Tabas and Ron, 2011) . CHOP is a member of the CCAAT/enhancer-binding protein family of transcription factors and can be induced by all three unfolded protein response arms, although the PERK-Eukaryotic initiation factor 2-(eIF2)-ATF4 pathway is essential (Szegezdi et al., 2006) . CHOP functions mainly as a dominant-negative regulator of gene expression (Ron and Habener, 1992; Jauhiainen et al., 2012) . The mechanism by which CHOP induces apoptosis involves repression of anti-apoptotic genes and induction of pro-apoptotic genes, among them the B-cell lymphoma 2 (Bcl-2) Bcl-2 homology domain 3-only proteins Bcl-2 interacting mediator of death (Bim) (Puthalakath et al., 2007; Ghosh et al., 2012) and p53 upregulated mediator of apoptosis (Puma) (Galehdar et al., 2010; Ghosh et al., 2012) .
CHOP has been reported to promote neuronal death in models of neurodegeneration (Milhavet et al., 2002; Reijonen et al., 2008; Chigurupati et al., 2009; Prasanthi et al., 2011) and after acute brain insults (Tajiri et al., 2004; Cui et al., 2007; He et al., 2012) , and, reasonably, CHOP inhibition has been proposed as a neuroprotective strategy. Recent studies, however, showed that CHOP can be anti-apoptotic, promoting neuronal survival after endoplasmic reticulum stress, hypoxia and protecting against oligodendrocyte death (Gow and Wrabetz, 2009; Halterman et al., 2010; Rouschop et al., 2010; Chen et al., 2012) . Although CHOP has been reported to be induced after seizures (Murphy et al., 2010; Chihara et al., 2011) , no functional studies have been undertaken. We, therefore, investigated the role of CHOP in seizure-induced neuronal death in experimental and human epilepsy.
Materials and methods

Mouse seizure models
All animal experiments were performed in accordance with the principles of the European Communities Council Directive (86/609/EEC), and procedures were approved by the Research Ethics Committee of the Royal College of Surgeons in Ireland. Adult C57BL/6 wild-type (Harlan), Chop + /À and Chop À /À , mice (Jackson Laboratory; B6.129S-Ddit3 tm1Dron /J; Zinszner et al., 1998) were used. Chop À /À mice were originally back-crossed to C57BL/6 background for at least five generations and were, subsequently, further back-crossed. Mice were anaesthetized and placed in a stereotaxic frame. Three partial craniectomies were performed to affix cortical skull-mounted EEG electrodes (Plastics One), and EEG was recorded using a Grass Comet digital EEG. A guide cannula was affixed for intra-amygdala targeting, and the skull assembly was fixed in place with dental cement. After baseline EEG, kainic acid (0.3 mg in 0.2 ml phosphate buffered saline PBS) (Ocean Produce International) was microinjected into the basolateral amygdala. Non-seizure control mice received 0.2 ml of intra-amygdala vehicle. Forty minutes later, mice received intraperitoneal lorazepam (6 mg/kg).
Seizure preconditioning was induced by a single intraperitoneal injection of kainic acid (15 mg/kg in 0.2 ml PBS) (Hatazaki et al., 2007) . Sham-preconditioned animals received the same volume of PBS. To model epileptic tolerance, status epilepticus was induced after preconditioning by intra-amygdala microinjection of kainic acid (0.3 mg in 0.2 ml PBS). A group of sham-preconditioned mice also underwent status epilepticus induced by intra-amygdala kainic acid and served as injury control subjects. Lorazepam (6 mg/kg, intraperitoneal) was administered to all animals 40 min after intra-amygdala injections. In additional mice, status epilepticus was induced by subcutaneous injection of pilocarpine (Sigma-Aldrich) at 340 mg/kg body weight, 20 min after injection of methyl-scopolamine (1 mg/kg) (Sigma-Aldrich).
Mice were saline-perfused under deep anaesthesia to remove intravascular blood components, and brains were either flash-frozen whole in 2-methylbutane at 30 C for histopathology, perfused with 4% paraformaldehye for immunofluorescence and in situ hybridization, dissected on ice to obtain whole hippocampus and cortex or microdissected to obtain the different hippocampal subfields [cornu ammonis (CA)1, dentate gyrus and CA3]. before intra-amygdala kainic acid, respectively. Vehicle mice received dimethyl sulphoxide alone. For p53 inhibitor studies, wild-type and Chop À /À mice received intraperitoneal vehicle (0.1% dimethyl sulphoxide in PBS) or pifithrin-[1-(4-methylphenyl)-2-(4,5,6,7tetrahydro-2-imino-3(2H)-benzothiazolyl)-ethanone hydrobromide] (Sigma-Aldrich) at 4 mg/kg as described previously (Engel et al., 2010a) . Pifithrin-was administered 24 h before, 1 h after status epilepticus and on the first and second day after status epilepticus.
Quantification of electroencephalography
Digitized EEG recordings were analysed off-line using manual assessment and automated software as described . The duration of high-frequency (45 Hz) and high-amplitude (42 times baseline) polyspike discharges of 55 s duration, which are synonymous with injury-causing electrographic activity, was counted by a reviewer blind to the treatment. Further EEG analysis was performed by uploading EEG into Labchart7 software (ADInstruments) to calculate amplitude of the EEG signal.
Epilepsy monitoring
Continuous EEG recordings were performed using implantable EEG telemetry units (Data Systems International) (Engel et al., 2010a, b) . Transmitters (model F20-EET, Data Sciences International) were implanted in a subcutaneous pocket and were used to record bilateral EEG from skull. EEG data were acquired beginning on the third day after status epilepticus until day 14. Seizures were defined as high frequency (45 Hz), high amplitude (42 times baseline) polyspike discharges of 55 s duration. Additional epilepsy monitoring was performed 4 weeks post-status epilepticus by continuous video-only monitoring of generalized tonic-clonic seizures, as described (Jimenez-Mateos et al., 2012 ).
Object location memory task
Object location memory experiments were performed as described previously (Wimmer et al., 2012) with minor modifications. On the training day, mice were placed in a training arena consisting of a 30 Â 30 Â 20 cm box with transparent walls, for four 10-min sessions with an inter-session interval of 3 min, during which mice were returned to their home cages. The first session consisted of a context habituation period without objects in the arena. During the next three sessions, mice were placed in the training arena with two distinct objects. The objects and the arenas were wiped with 70% ethanol before each session. Twenty-four hours after training, mice were placed in the original training arena for 10 min with one object displaced to a new location, whereas the other object was not moved. Exploration was recorded during training and testing on a digital camera for subsequent scoring of time spent exploring objects. Total distance travelled, velocity and time spent in the demarcated central zone of the arena were automatically analysed using Ethovision videotracking (Ethovision). Exploration of objects was measured manually by stopwatch and was defined as the amount of time mice were oriented towards an object with its nose within 1 cm of it, and it was scored by an experimenter blinded to treatment and genotype.
Human brain tissue samples
This study was approved by the Ethics (Medical Research) Committee of Beaumont Hospital, Dublin (05/18), and written informed consent was obtained from all patients. Briefly, control (autopsy) hippocampus (n = 4; C1-C4) and temporal cortex (n = 5; C5-C9) were obtained from five individuals from the Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD, USA. Patients (n = 12) were referred for surgical resection of the temporal lobe for the treatment of intractable temporal lobe epilepsy. After temporal lobe resection, the hippocampus and/or neocortex was obtained and frozen in liquid nitrogen and was stored at À 70 C until use. A pathologist (M.F.) assessed hippocampus (n = 9) and neocortex (n = 3) and described the presence of hippocampal sclerosis and other pathological changes. Samples were then processed for protein analysis by western blot. Full details of control and patient pathology and clinical data can be found elsewhere (McKiernan et al., 2012) .
RNA extraction and real-time quantitative polymerase chain reaction
RNA extraction was undertaken as previously described using TRIzol Õ (Invitrogen) (Hatazaki et al., 2007) . Briefly, 1 mg of total RNA was used to generate complementary DNA by reverse transcription using SuperScript Õ II reverse transcriptase enzyme (Invitrogen). Quantitative real-time PCR was performed using a LightCycler 1.5 (Roche Diagnostics) in combination with QuantiTect Õ SYBR Õ Green PCR kit (Qiagen) as per manufacturer's protocol, and 1.25 mM of primer pair was used. Data were analysed by LightCycler 1.5 software, data were normalized to expression of b-actin and represented as relative quantification values. Primers were designed using Primer3 software (http:// frodo.wi.mit.edu) and were verified by basic local alignment search tool BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Primers sequences: Arc: forward 5 0 -TGACTCACAACTGCCACACA-3 0 , reverse-5 0 -ATGAGGAA GCCAGATCGTGT-3 0 ; Chop: forward 5 0 -GAATAACAGCCGGAAC CTGA-3 0 , reverse 5 0 -CGTTTCCTGGGGATGAGATA-3 0 ; WAF; wild-type p53-activatedfragment;Cip1;Cdkinteractingprotein1;p21 WAF/Cip1 :forward 5 0 -CCGTGGACAGTGAGCAGTTG-3 0 , reverse 5 0 -GCAGCAGGGCAG AGGAAGTA-3 0 ; p53: forward 5 0 -CGGGTGGAAGGAAATTTGTA-3 0 , reverse 5 0 -GCACAAACACGAACCTCAAA-3 0 ; Mdm2: forward 5 0 -GAAATGAATCCTCCCCTTCC-3 0 , reverse 5 0 -CTGTCAGCTTTTTGC CATCA-3 0 ; spliced Xbp1: forward 5 0 -GAGTCCGCAGCAGGTG-3 0 , reverse 5 0 -AAGGGAGGCTGGTAAGGAA-3 0 .
Microarray analysis
Microarray studies were undertaken according to previously described techniques (Hatazaki et al., 2007) at an Affymetrix authorized service provider (University College Dublin, Dublin, Ireland). Briefly, total RNA was extracted from control wild-type mice and wild-type and Chop À / À mice 6 h after status epilepticus and was hybridized to the Mouse Genome 430 2.0 Genechip array. Affymetrix GeneChip image files were analysed by robust multichip analysis using RMAExpress 0.5 (http://rmaexpress.bmbolstad.com). Data were log transformed, and the threshold for significant regulation was set at 2-fold to retain genes that exhibit a biologically meaningful level of regulation, but not exclude certain genes that, because of high constitutive expression, may show lower degrees of change. Gene ontology and function were assigned by interrogating the database for annotation, visualization and integrated discovery (http://david.abcc.ncifcrf.gov/) and the published literature.
In situ hybridization
The probe to detect Chop was 5 0 -digoxigenin-labelled, 2-O,4-Cmethylene bicyclonucleoside monomer containing oligonucleotide. The sequence was the reverse complement to the mature Chop messenger RNA; /5DigN/GGCCATAGAACTCTGACTGGAA (Exiqon). Probes were incubated 1:200 in hybridization buffer overnight at 60 C. On the next day, anti-digoxigenin-alkaline phosphatase antibody (1:1000; Roche) was incubated, and on the following day, sections were washed, and colour substrate solution (Roche) was added to each slide until signal appeared.
Western blot analysis
Western blotting was performed as previously described (Engel et al., 2010a) . Proteins were extracted from hippocampus, separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis SDS-PAGE and transferred to nitrocellulose membranes and then immunoblotted with the following primary antibodies: ATF-4, ATF-6, CHOP, murine double minute 2 (MDM2) MDM2 and p53 (Santa Cruz Biotechnology); eIF2, Phospho-eIF2 (Ser51) and Lamin A/C (Cell Signaling Technology); ionotropic glutamate receptor subunit 6/7 (GluR6/7) GluR6/7 (Millipore); Lys-Asp-Glu-Leu (KDEL) KDEL (Assay Designs); PUMA (ProSci Inc.) and b-actin and -tubulin (Sigma-Aldrich). Horseradish peroxidaseconjugated antibodies (Cell Signaling Technology) were then applied and used as secondary antibodies. Protein bands were visualized using SuperSignal Õ West Pico Chemiluminescent Substrate (Pierce). Gel band image densities were captured using a Fuji-film LAS-3000 and analysed using Alpha-EaseFC4.0 software.
DNA damage assessment
A competitive enzyme-linked immunosorbent assay ELISA (Cambridge Bioscience) was used for the quantitative measurement of 8-hydroxydeoxyguanosine. Samples with unknown 8-hydroxydeoxyguanosine content and standards were first added to an 8-hydroxydeoxyguanosine/bovine serum albumin conjugate plate and incubated for 10 min at room temperature. Anti-8-hydroxydeoxyguanosine monoclonal antibody was added and incubated for 1 h at room temperature, followed by incubation with the horseradish peroxide-conjugated secondary antibody for 1 h. The 8-hydroxydeoxyguanosine content in samples was determined by comparison with the predetermined 8-hydroxydeoxyguanosine standard curve.
Histopathology
Fresh-frozen coronal brain sections at the level of the dorsal and ventral hippocampus were air-dried, fixed in formalin and stained with antibodies against NeuN (Chemicon) and detected by goat anti-mouse Alexa Fluor Õ 568 (BioSciences Ltd). Neuronal damage was assessed by Fluoro-Jade B staining (Millipore) (Engel et al., 2010a) . Analysis of DNA damage was performed using a fluorescein-based terminal deoxynucleotidyl dUTP nick end-labelling technique (Promega). Sections were mounted in medium containing 4,6 diamidino-2-phenylindole (DAPI; Vector Laboratories) to visualize nuclei. Sections were imaged using a Nikon 2000s epifluorescence microscope with a Hamamatsu Orca 285 camera (Micron-Optical). Semi-quantification of damaged and/or surviving cell numbers was performed for the entire CA3 subfield, beginning at the border with CA2 through to the end of CA3c/ CA4 within the hilus of the dentate gyrus and for the entire CA1 subfield beginning at border with CA2 through to the end of CA1. For area measurements of the dentate gyrus, sections were stained with DAPI and delineated using MetaMorph. Next, DAPI-positive cells in the delineated area were counted with ImageJ, and area was divided by total count of DAPI positive cells. Counts were the average of two adjacent sections assessed by an observer masked to experimental group/ condition.
Confocal microscopy
For confocal microscopy, animals were transcardially perfused with 4% paraformaldehyde, post-fixed and cryoprotected in sucrose before sectioning. Sections were rinsed and treated with PBS containing 0.1% Triton TM X-100 and 1% foetal calf serum followed by incubation with the primary antibodies; p53 (Novocastra) and cleaved caspase 3 (Cell Signaling Technology). Sections were washed again and incubated with secondary antibodies coupled to Alexa Fluor Õ 488 or Alexa Fluor Õ 568 (BioSciences Ltd). Sections were then coverslipped with Fluorosave TM . Confocal images were acquired with a Leica TCR 6500 microscope equipped with four laser lines (405, 488, 561 and 653 nm) using a Â 63 immersion oil objective.
Diaminobenzidine staining
Mice were perfused with 4% paraformaldehyde, brains extracted, post-fixed and cryoprotected in 30% sucrose solution, and 30-mm sagittal sections were cut on a Leica cryostat. Next, brain sections were pretreated for 1 h with 1% bovine serum albumin, 5% foetal bovine serum and 0.2% Triton TM X-100 and then incubated with p53 (Novocastra) primary antibody. Finally, brain sections were incubated in avidin-biotin complex using the Elite Õ VECTASTAIN Õ kit (Vector Laboratories). Chromogen reactions were performed with diaminobenzidine (Sigma-Aldrich) and 0.003% hydrogen peroxide for 10 min. Sections were coverslipped with Fluorosave TM .
Plasmids and luciferase reporter experiments
The putative Mdm2 promoter was cloned by PCR amplification from mouse genomic DNA of a fragment containing the region À1923 to + 193 relative to the transcription initiation site and cloned into the SacI and HindIII sites of the pGL3-Basic vector (Promega). The CHOP expression plasmid was similarly cloned by PCR amplification of mouse complementary DNA and cloned into the pIRES2-enhanced green fluorescent protein (EGFP) biscistronic vector (Clontech). The integrity of all constructs was verified by sequencing. SHSY5y cells were transfected with the MDM2-pGL3 plasmid along with the Renilla Luciferase expressing plasmid, phRL-TK-luc (Promega) and the plasmid expressing CHOP or the empty vector control using Metafectene Õ (Biontex) as per the manufacturer's instructions. After 24 h, cells were lysed in passive lysis buffer (Promega), and luciferase activity was measured using the Dual Luciferase Reporter Assay System (Promega), and the resulting luminescence was monitored using a Berthold luminometer. Luminescence was calculated as a ratio of Firefly/Renilla activity and expressed relative to control transfected wells.
Simulated post-mortem delay
Hippocampi were extracted from mice (adult C57Bl/6) after deep anaesthesia with pentobarbital and decapitation. Hippocampi were either frozen immediately ('surgical' control) or frozen 4 or 8 h after being left at room temperature (simulated post-mortem interval). Samples were then processed for western blotting as described earlier in the text.
Data analysis
Data are presented as means AE standard error of the mean (SEM). Data were analysed using ANOVA with post hoc Fisher's protected least significant difference test, Student's t-test for two-group comparison and Mann-Whitney test for non-parametric test (StatView).
Significance was accepted at P 5 0.05.
Results
CHOP is upregulated in surviving regions of the hippocampus after status epilepticus
We first examined CHOP in a well-characterized model of status epilepticus produced by intra-amygdala microinjection of the glutamate receptor agonist kainic acid in mice (Engel et al., 2010a; Murphy et al., 2010) . Status epilepticus caused damage to the ipsilateral CA3 subfield, whereas neurons in the CA1 subfield and dentate gyrus were largely spared ( Fig. 1A) . Analysis of lysates from whole hippocampus determined all three branches of the unfolded protein response were activated after status epilepticus, with increased eIF2 phosphorylation and ATF4 protein levels, increased ATF6 cleavage and X-box binding protein 1 (Xbp1) Xbp1 splicing ( Fig. 1B-D) . Increased levels of Chop messenger RNA ( Fig. 1E ) and CHOP protein ( Fig. 1F and G) were detected by 8 h. CHOP protein also increased in the nucleus after status epilepticus ( Fig 1H) , which may be important for CHOP to execute its transcriptional functions (Jauhiainen et al., 2012) . CHOP induction after seizures was not unique to this kainic acid model and occurred at both transcript and protein level after status epilepticus induced by the cholinergic agonist pilocarpine ( Fig. 1I-K) .
To determine whether CHOP induction was restricted to damaged parts of the hippocampus, we measured transcript levels in microdissected CA3, CA1 and the dentate gyrus. Surprisingly, Chop messenger RNA was induced in non-damaged (CA1, dentate gyrus) as well as damaged (CA3) subfields ( Fig. 2A ). Western blot analysis confirmed CHOP protein increased in each subfield ( Supplementary Fig. 1A) . In situ hybridization also showed Chop messenger RNA was present in neurons in each subfield ( Supplementary Fig. 1B ).
CHOP upregulation in response to neuroprotective manipulations in vivo
To investigate whether CHOP was associated with neuronal survival in other contexts, we subjected additional mice to a single episode of brief generalized seizure activity produced by intraperitoneal injection of 15 mg/kg kainic acid. These seizures do not damage the hippocampus, and instead, they activate endogenous programmes of neuroprotection that protect against status epilepticus (Hatazaki et al., 2007) . CHOP protein was increased in all three major subfields of the hippocampus after seizure preconditioning (Fig. 2B ). We also treated mice with the endoplasmic reticulum stress inhibitor salubrinal, which blocks eIF2 phosphorylation and has been reported to protect against seizure-induced neuronal death in vivo (Sokka et al., 2007; Moon et al., 2011) . An intracerebroventricular injection of salubrinal increased CHOP protein in the mouse hippocampus ( Fig. 2C) and decreased neuronal death after intra-amygdala kainic acid-induced seizures ( Fig. 2D and E) .
Normal hippocampal architecture and response to kainic acid in Chop À / À mice If CHOP is functioning to prevent rather than promote seizure-induced neuronal death, then loss of CHOP should increase seizure damage. To test this idea, we studied mice lacking CHOP (Chop À/À ) (Zinszner et al., 1998) . CHOP-deficient mice were born at expected rates, developed normally and displayed no abnormal brain morphology. Coronal brain sections stained for the neuronal marker NeuN confirmed normal hippocampal architecture (Supplementary Fig. 2A and B) . No differences were observed between wild-type and Chop À/À mice for basal levels of the kainate receptor GluR6/7 ( Supplementary Fig. 2D and E). We then equipped mice with skull-mounted electrodes and recorded EEG after inducing status epilepticus by intra-amygdala kainic acid. Levels of the activity-regulated gene Arc were increased to the same level in wild-type and Chop À/À mice subject to status epilepticus ( Supplementary Fig. 2F ). No differences were observed between wild-type, Chop + /À and Chop À /À animals in total seizure time, EEG amplitude or frequency ( Supplementary Fig. 2G-I) . Seizure-induced DNA damage was also similar between Chop À/ À mice and wild-type animals ( Supplementary Fig. 3 ).
Increased hippocampal damage in Chop À / À mice after status epilepticus We next examined seizure-induced neuronal death 72 h after status epilepticus in wild-type, Chop + /À and Chop À /À mice (Fig. 3) . Mice lacking CHOP displayed more damage to the CA3 subfield compared with heterozygous and wild-type littermates ( Fig. 3A and Supplementary Fig. 4A ). Extensive neuronal death was also present in hippocampal subfields of Chop À /À mice that do not normally undergo seizure-induced neuronal death in this model, including the CA1 and dentate gyrus ( Fig. 3B and C and Supplementary Fig. 4B and C) . Increased damage in Chop À /À mice was also found in the ventral hippocampus ( Supplementary  Fig. 5) . The difference in damage was also present in Chop À /À mice killed 24 h after status epilepticus ( Supplementary Fig. 6 ). Mice lacking CHOP also displayed increased seizure-induced neuronal death in response to pilocarpine-induced status epilepticus (Fig. 3D ). We also examined the contralateral hippocampus of mice, as this is another area normally undamaged in the model (Mouri et al., 2008) . Western blot analysis determined CHOP was strongly upregulated in the contralateral hippocampus ( Supplementary Fig. 7A and B) and histopathology revealed extensive neurodegeneration in the contralateral hippocampus of Chop À /À mice but not wild-type animals after status epilepticus ( Supplementary Fig. 7C-F) .
Neuroprotection by endoplasmic reticulum stress preconditioning is lost in Chop À/ À mice We next examined seizure damage in wild-type and Chop À/À mice previously exposed to mild endoplasmic reticulum stress. Mice were given an intracerebroventricular injection of tunicamycin 8 h before status epilepticus at a dose that increased CHOP and endoplasmic reticulum stress ( Supplementary Fig. 8 ) but did not cause cell death. In wild-type mice, the endoplasmic reticulum stress preconditioning protected against seizure-induced neuronal death (Fig. 3E) . In contrast, seizure-induced neuronal death was exacerbated by endoplasmic reticulum stress preconditioning in Chop À/À mice (Fig. 3E) . 
Increased p53 levels after status epilepticus in the absence of CHOP
The mechanism by which CHOP regulates cell death is thought to involve inducing or curtailing expression of a subset of apoptosisassociated genes (Oyadomari and Mori, 2004; Jauhiainen et al., 2012) . To identify which genes might be dysregulated in Chop À/ À mice, we profiled gene expression in wild-type and Chop À /À mice after status epilepticus using microarrays (Hatazaki et al., 2007) . Overall, status epilepticus resulted in similar numbers and fold changes of gene expression between wild-type and Chop À/À mice (Fig. 4A-C) . However, the number of genes involved in the regulation of cell death and the p53 pathway was higher in Chop À /À mice compared with wild-type animals (Fig. 4D) . In particular, expression of multiple p53-regulated genes was increased in Chop À/ À mice (Fig. 4E) .
To confirm that an absence of CHOP resulted in higher p53 activity, we measured the expression of p21 WAF/Cip1 after status epilepticus, a marker of p53 activity in this model (Engel et al., 2010a) . p21 WAF/Cip1 levels after status epilepticus were higher in Chop À /À mice compared with wild-type animals (Fig. 4F ). Protein levels of p53, but not messenger RNA, were higher in Chop À /À mice after status epilepticus compared with wild-type animals ( Fig. 4G-J) . There was no basal difference in p53 protein levels between Chop À /À mice and wild-type animals ( Fig. 4J and K) . Analysis of the temporal relationship between p53 and neuronal http://brain.oxfordjournals.org/ Downloaded from death showed p53 levels peaked $4-24 h after status epilepticus, returning to baseline thereafter in wild-type mice, whereas p53 levels continued to increase over time in Chop À/ À mice ( Fig. 4J and K) . Neuronal death also showed an increase between 24 and 72 h in Chop À/À mice but not in wild-type animals (Fig. 4L ).
Inhibition of p53 in Chop À / À mice reduces seizure-induced neuronal death to wild-type levels Immunohistochemistry confirmed high p53 levels in neurons in all major hippocampal subfields in Chop À/À mice that contrasted the p53 staining in wild-type animals after status epilepticus ( Fig. 5A  and B ). Consistent with this promoting apoptosis, we observed more cleaved caspase 3 immunoreactivity in p53-positive CA3 neurons in Chop À/À mice compared with wild-type animals (Fig. 5C ).
We previously reported that Puma is the effector of p53induced neuronal death after status epilepticus (Engel et al., 2010a) . We found Puma protein levels were higher in the hippocampus of mice lacking CHOP after status epilepticus compared with wild-type animals ( Fig. 5D and E) .
If increased p53 levels are responsible for the enhanced seizure-induced neuronal death in Chop À/ À mice, then p53 inhibition should prevent that injury. We tested this idea by treating mice with the p53 transcriptional inhibitor pifithrin- (Engel et al., 2010a) . We confirmed pifithrin-blocked p53 activity by assaying p21 WAF/Cip1 levels after status epilepticus (Fig. 5F ) and found that the increased seizure-induced hippocampal damage in Chop À/À mice was prevented by pifithrin- (Fig. 5G  and H) . 
MDM2 is a target of CHOP
The accumulation of p53 protein in Chop À/À mice after status epilepticus along with unchanging p53 messenger RNA is consistent with a failure of the post-translational mechanisms controlling p53 levels. Cellular levels of p53 protein are regulated by the protein product of the murine double minute 2 (Mdm2) gene via post-translational ubiquitination and degradation by the proteasome (Toledo and Wahl, 2006) . Bioinformatic analysis of the MDM2 promoter using the Algen Promo database (Pubmed identifier PMID: 11847087; 12824386) revealed putative binding sites for CHOP (Fig. 6A) . To investigate whether CHOP can alter the expression of Mdm2, we cloned a 2.1-kB fragment containing $1.9 kb of sequence 5 0 to the transcription initiation site of Mdm2 in the mouse genome into the promoterless pGL3-basic vector (see 'Materials and methods' section). Overexpressing CHOP was sufficient to increase expression of luciferase driven by the MDM2 promoter (Fig. 6A ). Also supporting CHOP as a regulator of MDM2, we found Mdm2 transcript levels increased after status epilepticus in wild-type but not in Chop À/À mice (Fig. 6B ). MDM2 protein levels were also lower after status epilepticus in Chop À/À mice than wild-type animals ( Fig. 6C and D) . Last, seizure preconditioning increased CHOP and MDM2 levels in wild-type mice but not in Chop À/À mice (Fig. 6E-G) .
Increased spontaneous seizures and ongoing neurodegeneration after status epilepticus in Chop À / À mice Mice develop spontaneous recurrent seizures within a week of status epilepticus induced by intra-amygdala microinjection of (green) and apoptosis marker cleaved caspase 3 (cl Casp3, red) in non-seizure wild-type and wild-type and Chop À/À 24 h after status epilepticus. Note only limited p53 and cleaved caspase 3 in wild-type mice after status epilepticus compared with Chop À/À mice. Western blot (D) and corresponding graph (E) showing higher Puma levels in the hippocampus of Chop À/À mice compared with wild-type mice 24 h after status epilepticus (n = 3/group). -Tubulin is shown as loading control. (F) Graph showing the p53 inhibitor pifithrin-reduced p21 WAF/Cip1 messenger RNA levels 4 h after status epilepticus (n = 4/group). (G) Graph showing Fluoro-Jade B-positive cells in hippocampus 72 h after status epilepticus in wild-type and Chop À/À mice treated with vehicle or pifithrin-. Cell death was increased in vehicle-treated Chop À/À mice and this was reversed by pifithrin-(n = 3-7/group). (H) Representative photomicrographs showing Fluoro-Jade B staining in hippocampus from wild-type and Chop À/ À mice treated with vehicle or pifithrin-. Statistically significant differences are indicated by *P 5 0.05. Scale bar = 250 mm (A and H), 50 mm (C). Data presented as mean AE SEM. DAPI = 4 0 ,6-diamidino-2-phenylindole; FJB = Fluoro-Jade B; PFT = pifithrin-; SE = status epilepticus; wt = wild-type. kainic acid, with a subsequent rise in seizure frequency by 3 weeks (Fig. 7A and see Mouri et al., 2008; Jimenez-Mateos et al., 2010) . During this period, the CA3 subfield develops neuron loss and astrogliosis and is the source of spontaneous seizures (Fig. 7B ) (Li et al., 2008) . Hippocampal lysates from epileptic mice contained higher levels of spliced Xbp1 but normal levels of ATF4 and cleaved ATF6 (Fig. 7C-E ), suggesting that only the survival-promoting IRE1 branch of the unfolded protein response is active in epilepsy (Lin et al., 2007) .
We next equipped wild-type and Chop À/À mice with EEG telemetry units to investigate whether increased damage after status epilepticus affected later spontaneous seizures, undertaking continuous EEG recordings for 2 weeks. Wild-type mice began experiencing spontaneous seizures 3-4 days after status epilepticus, whereas epileptic seizures emerged earlier in Chop À /À mice (Fig. 7F) . Chop À/ À mice had more frequent spontaneous seizures than wild-type mice, although the duration of individual seizures, when they occurred, was similar ( Fig. 7G-I) . No seizures were detected in Chop À/À mice that received only intra-amygdala saline (n = 2). Consistent with these data, we noted a tendency towards higher seizure frequency as well as greater mortality in Chop À/ À mice during video-only monitoring of generalized tonic-clonic seizures 4 weeks after status epilepticus ( Supplementary Fig. 9 ).
Ongoing cell death was rarely found in the hippocampus of wild-type mice 2 weeks after status epilepticus (Fig. 8A) . In contrast, there was substantial ongoing neuronal death in the hippocampus of Chop À /À mice 2 weeks after status epilepticus (Fig. 8A) . Reduced neuron counts were also found in the granule cell layer of the dentate gyrus of Chop À/À mice (Fig. 8B) .
We next examined performance of wild-type and Chop À /À mice in a simple hippocampus-dependent object-place recognition task (Wimmer et al., 2012) . Animals were habituated to two objects. The position of one of these objects is then moved before the next trial, which normally produces an increase in time spent with the newly placed object (Wimmer et al., 2012) . There were no differences in performance of the task between naïve wild-type and naïve Chop À/ À mice ( Supplementary Fig. 10A-E ). Next, we examined the performance of epileptic wild-type and epileptic Chop À /À mice, 3 weeks after status epilepticus. There were no differences in distance travelled or velocity, but both groups of epileptic mice spent less time in open areas during the initial training phase compared with non-seizure control mice ( Fig. 8C and Supplementary Fig 10F-I) . In contrast, epileptic Chop À/À mice, but not epileptic wild-type mice, displayed a significant deficit in time spent with the novel object, suggesting a memory deficit (Fig. 8D) .
Finally, we examined hippocampus from epileptic mice at the end of telemetry monitoring. Western blot analysis showed higher p53 and lower MDM2 levels in Chop À/À mice compared with wild-type animals ( Fig. 8E and F) .
CHOP is overexpressed in experimental and human temporal lobe epilepsy
Finally, we examined CHOP in experimental and human epilepsy (Fig. 9 ). CHOP protein levels were higher in the hippocampus of chronically epileptic mice ( Fig. 9A and B) . In human brain, CHOP was present at low levels in autopsy control hippocampus (Fig. 9C) . In contrast, CHOP was detected in all samples of non-sclerotic hippocampus from patients with temporal lobe The regions with putative C/EBP binding sites are denoted as vertical black bars. Graph: SHSY5y cells were transfected with the MDM2-pGL3 plasmid and the phRL-TK-luc Renilla luciferase plasmid alongside either a CHOP expression plasmid or its empty vector control (Con). After 24 h, cells were lysed, and luciferase activity was monitored (n = 12/ group). (B) Mdm2 messenger RNA levels in wild-type mice 6 h after status epilepticus when compared with wild-type control and Chop À /À mice 6 h after status epilepticus (n = 4 -5/group). (C and D) Western blot and corresponding graph showing MDM2 protein levels in wild-type and Chop À/À mice 6 h after status epilepticus (n = 3/group). (E and F) Chop and Mdm2 messenger RNA levels after seizure preconditioning (n = 5/ group). (G) Mdm2 levels in Chop À/À mice 4 h after preconditioning (n = 4/group). Statistically significant differences are indicated by *P 5 0.05; ***P 5 0.001. Lanes in (C) were run on the same gel but were non-contiguous (white lines). Data presented as mean AE SEM. DAPI = 4 0 ,6-diamidino-2-phenylindole; FJB = Fluoro-Jade B; PFT = pifithrin-; SE = status epilepticus; wt = wild-type.
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Brain 2013: Page 11 of 16 | 11 by guest on October 6, 2016 http://brain.oxfordjournals.org/ epilepsy (Fig. 9C ). CHOP levels were not different from autopsy control in sclerotic hippocampus from patients with temporal lobe epilepsy (Fig. 9D ). CHOP protein level was also higher in non-sclerotic neocortex from patients with temporal lobe epilepsy compared with autopsy control subjects ( Fig. 9E and F) . A simulated autopsy delay using mouse brain showed CHOP protein levels in the hippocampus are stable over the period corresponding to the maximal delay in the human control subjects ( Supplementary Fig. 11 ).
Discussion
The present study demonstrates that CHOP is upregulated in surviving neurons and in chronic experimental and human epilepsy. Critically, we show that an absence of CHOP increases neuronal death in models of prolonged seizures. This was associated with a much stronger p53 induction than normal, and reporter assays show CHOP can promote Mdm2 transcription, which may restrain p53 function. We must be cautious in assigning clinical importance to any single pathway, but given the exacerbation of damage and protracted neurodegeneration in mice lacking CHOP after status epilepticus, these data indicate that CHOP-inducing agents may be a potential strategy for protection against seizure-induced brain injury and, perhaps, anti-epileptogenesis.
Both endoplasmic reticulum stress and DNA damage are thought to contribute to the pathogenesis of several neurological and neurodegenerative diseases, and CHOP has been proposed as a common effector (Oyadomari and Mori, 2004; Tajiri et al., 2004; Puthalakath et al., 2007; He et al., 2012) . The present study demonstrates that CHOP transcript and protein is induced in models of status epilepticus in mice, thus extending previous work (Murphy et al., 2010 ). An early finding here was that CHOP was induced in damage-resistant subfields of the ipsilateral and contralateral hippocampus and also by brief non-harmful seizures that activate endogenous neuroprotective programmes (Hatazaki et al., 2007) . Our data are, therefore, not consistent with an exclusively pro-apoptotic role for this transcription factor but instead suggest a context-dependent function for CHOP. We cannot, however, exclude that CHOP may exert a pro-as well as anti-apoptotic effect on the ipsilateral CA3 subfield where damage occurs and where CHOP was also induced. Evidence supporting CHOP as a survival factor was provided by our analysis of Chop À/À mice subject to status epilepticus. The standard injury in the model is a lesion restricted to the ipsilateral CA3 subfield (Mouri et al., 2008) . In Chop À /À mice, the ipsilateral CA3 subfield was more damaged than normal, and there was seizure-damage to the ipsilateral CA1 and dentate gyrus and the contralateral hippocampus. The increased vulnerability was independent of the means of seizure induction, also occurring when pilocarpine was used to produce status epilepticus. More prolonged seizures could be a cause of additional damage, but this was excluded by EEG analysis and measurement of activity-regulated and DNA damage-induced gene expression, which was similar to wild-type animals. Taken together, this supports a requirement of CHOP for neuronal survival after status epilepticus.
Our data are compatible with the original function of CHOP as a proto-oncogene (Forus et al., 1994) and the survival-promoting functions of CHOP in some models of neuronal injury (Southwood et al., 2002; Song et al., 2008; Halterman et al., 2010) . This contrasts studies where CHOP was reported to promote neuronal death (Silva et al., 2005; Galehdar et al., 2010; Prasanthi et al., 2011; Ghosh et al., 2012) , including after global ischaemia (Tajiri et al., 2004) and subarachnoid haemorrhage (He et al., 2012) .
There are examples of a single protein having both pro-and anti-apoptotic functions in brain injury (Beurel and Jope, 2006) . Contributions of pro-apoptotic Bcl-2 family proteins to cell death also differ between neurological injuries (Engel et al., 2011) . The timing and duration of endoplasmic reticulum stress are known to be critical determinants of pro-or anti-apoptotic outcome (Lin et al., 2007) , and the functions of CHOP may also be context-dependent. However, differences cannot be readily accounted for by the scale or onset-offset of CHOP induction (Tajiri et al., 2004; Prasanthi et al., 2011; He et al., 2012) , use of short-interfering RNA versus genetic knockout to modulate CHOP (Tajiri et al., 2004; Halterman et al., 2010; He et al., 2012) , and it is not a brain region-specific effect (Tajiri et al., 2004; Prasanthi et al., 2011) . The pro-and anti-apoptotic effects of CHOP may depend on differences in parallel signalling pathways or the duration of activity of individual branches of the unfolded protein response (Lin et al., 2007) .
The present study provides insight into the mechanism by which CHOP may protect against seizure-induced neuronal death. Microarrays indicated that although the categories of genes changed were similar between wild-type and Chop À /À mice after status epilepticus, the fold change of those regulating cell death was much larger in the absence of CHOP. This suggests CHOP modifies the extent to which genes can be transcribed, acting as a 'brake' on overexpression of genes (Jauhiainen et al., 2012) . The present work goes further, however, and identifies a specific role for CHOP in regulating the p53-MDM2 axis. Induction of p53 contributes to seizure-induced neuronal death (Morrison et al., 1996; Engel et al., 2010a, b) and in wild-type mice p53 levels peaked at 24 h and returned to baseline. In contrast, p53 protein levels continued to increase over time in Chop À/ À mice in line with progression of hippocampal damage. Indeed, neurodegeneration continued for weeks after status epilepticus in Chop À/À mice. The additional damage in Chop À/À mice was largely prevented by a p53 inhibitor, supporting p53 involvement. Induction of Puma, the effector of p53-induced neuronal death after seizures (Engel et al., 2010a) , was also higher in Chop À/À mice. An important mechanism regulating cellular levels of p53 involves MDM2. The ubiquitin-proteosome system is the major non-lysosomal pathway for degradation of proteins in cells, including p53, and MDM2 mediates p53 ubiquitination followed by degradation via the proteasome (Lavin and Gueven, 2006; Toledo and Wahl, 2006) . Reporter experiments here established CHOP can drive MDM2 expression, and we found that MDM2 was not induced after status epilepticus in CHOP-deficient mice. Thus, the supramaximal p53 levels in Chop À /À mice may result from a failure of this mechanism to restrain p53 (summarized in Supplementary  Fig. 12 ). However, MDM2 levels were normal in naïve Chop À /À mice, suggesting that CHOP is not involved in maintenance of basal MDM2 levels. Together, these results provide a mechanistic explanation for the damage-vulnerable phenotype in Chop À /À mice and add CHOP to the network of proteins that regulate the p53-MDM2 axis (Lavin and Gueven, 2006) .
The present study found higher CHOP levels in both experimental and human temporal lobe epilepsy. These are the first data on CHOP in epilepsy. If CHOP protects neurons from seizure-induced neuronal death, then we can speculate that the raised CHOP levels in hippocampus and neocortex in temporal lobe epilepsy patient material may be an adaptation to recurrent seizures that could limit further neuron loss. Consistent with this idea, CHOP levels were not elevated in sclerotic hippocampus where cell death may be ongoing (Mathern et al., 2002; Bernasconi and Bernhardt, 2010; Henshall and Meldrum, 2012) . The high levels of CHOP in chronic epilepsy where little or no ongoing cell death occurs, along with the continued degeneration of the hippocampus in Chop À /À mice after status epilepticus, support CHOP serving an anti-apoptotic function in epilepsy. However, as with previous studies in ischaemia (Moskowitz et al., 2010) , we must be cautious before assigning clinical importance to any single pathway.
In summary, the present study identifies CHOP as important for neuronal survival after status epilepticus and finds CHOP is upregulated in human epilepsy. CHOP may indirectly promote neuronal survival by restraining p53 induction via MDM2 upregulation. Given that excitotoxicity underlies various neurological and neurodegenerative diseases, these data caution against targeting CHOP for neuroprotection in acute and chronic diseases of the central nervous system and suggest CHOP delivery may protect against seizure-induced neuronal death and, perhaps, anti-epileptogenesis.
